• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Agios blood cancer drug lead jumps ship to Aprea Therapeutics

cafead

Administrator
Staff member
  • cafead   Mar 25, 2019 at 10:32: PM
via Swedish p53 cancer biotech Aprea Therapeutics has nabbed former Agios senior medical director Eyal Attar as its senior vice president and chief medical officer.

article source
 

<